Trials / Enrolling By Invitation
Enrolling By InvitationNCT07108803
European Research Group on Outcomes of Surgical Treatment of Infective Endocarditis
European Research Group on Outcomes of Surgical Treatment of Infective Endocarditis (ERGOSTE)
- Status
- Enrolling By Invitation
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,500 (estimated)
- Sponsor
- Azienda Sanitaria Universitaria Giuliano Isontina (ASU GI) · Unknown
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The European Research Group on Outcomes of Surgical Treatment of Infective Endocarditis (ERGOSTE) is a nascent large surgical registry that would encompass most relevant aspects of IE in Europe in the contemporary era.
Detailed description
ERGOSTE, Purposes: * To create a European multicenter retrospective database including a large number of patients undergoing surgical treatment for infective endocarditis (IE). * To perform epidemiologic analyses of IE-patients and involved pathogens. * To find independent predictors of early post-operative death. * To test ALL the scoring systems specifically developed to predict early death after surgery for infective endocarditis. * To devise a specific risk score for early postoperative death. * To explore early and late outcomes of these very difficult patients in order to establish optimal indications, techniques and timing of surgery. * To carry out a number of sub-analyses concerning the demographic parameters and variable clinical presentation of patients, type and severity of cardiac structural involvement, adopted valve prostheses and surgical techniques, and different involved microbiologic agents. * To lay experiential foundations of a prospective database on the topic.
Conditions
Timeline
- Start date
- 2025-06-01
- Primary completion
- 2025-08-31
- Completion
- 2025-08-31
- First posted
- 2025-08-07
- Last updated
- 2025-08-07
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT07108803. Inclusion in this directory is not an endorsement.